Taysha Gene Therapies Inc. (TSHA)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 96
-0.01
-0.1675%
$
1.43B Market Cap
- P/E Ratio
- Div Yield
2.85M Volume
-0.41 Eps
$ 5.97
Previous Close 
Want to track TSHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taysha Gene Therapies Inc. (TSHA) Statistics
Valuation metrics
Market Cap 1.43B
Enterprise value 1.23B
Trailing P/E (ttm) -15.57
Forward P/E -
PEG ratio 2.32
Price/Sales (ttm) 199.62
Price/Book (mrq) 10.31
Enterprise Value/Revenue 164.98
Enterprise Value/EBITDA -9.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.46M
Average volume (90 days) 3M
Price summary
52-Week low 2.34
52-Week high 7.3
Beta -
50-Day moving average 6.07
200-Day moving average 5.19
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -17.38%
Operating margin -17.74%
Operational effectiveness
Return on assets -0.43%
Return on equity -0.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.35
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.75
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 14.04%
Book value per share (mrq) 0.58
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
